This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

TeamHealth CEO Greg Roth Announces Plans To Retire Effective December 2014

Stocks in this article: TMH

KNOXVILLE, Tenn., Jan. 9, 2014 /PRNewswire/ -- Team Health Holdings Inc. ("TeamHealth" or the "Company") (NYSE: TMH), one of the largest providers of outsourced physician staffing solutions for hospitals in the United States, today disclosed that its Chief Executive Officer, Greg Roth, has announced his desire to retire from his role as an officer and member of the Company's Board of Directors (the "Board"), after nearly 10 years of successful leadership at the Company. Until a new CEO is appointed by the Board, Mr. Roth will continue in his current role with a targeted retirement date of December 2014. However, at the Board's request, Mr. Roth's retirement date could be extended until March 31, 2015. The Company's Board will begin an executive search for a new CEO, while Mr. Roth will remain as CEO and as a Board member throughout the search process to manage an orderly transition in the leadership of the Company.   

Mr. Roth joined TeamHealth in 2004 as President and Chief Operating Officer and was named CEO in 2008. During Roth's leadership, TeamHealth has grown from a privately held company with $1.0 billion in annual revenues that was primarily focused on emergency services to a publicly traded company with nearly $2.5 billion in annual revenues that now delivers multiple clinical service lines to more than 860 healthcare clients.

"Greg has been a valued and strategic leader who has made significant contributions to TeamHealth's growth," said Dr. Lynn Massingale, Co-Founder and Executive Chairman of the Company. "The Company has achieved important financial and performance milestones under his guidance, and we have built an exceptionally strong management team. We are pleased that Greg will remain in his current position for the next year to help with the search for his replacement and to effect a seamless transition once the new CEO is identified. As the Board begins its search for Greg's successor, we will consider both internal and external candidates."

"I have made a personal decision to retire, which will allow time for me to volunteer for not-for-profit organizations and serve on other corporate boards," said Mr. Roth. "I have thoroughly enjoyed working with the talented and caring people at TeamHealth who have made our successes possible. TeamHealth has a long-standing reputation as an organization focused on recruiting, retaining, and supporting outstanding clinicians who provide exceptional patient care with our client hospitals. I believe TeamHealth will continue to maintain its strong reputation as it successfully executes its strategy for years to come. TeamHealth is well positioned for the future, and I have great confidence in our clinicians, administrative employees and leadership team.  As a result of the extended leadership transition plan developed in conjunction with the Company's Board, I have committed to stay at TeamHealth for the remainder of the year, during which time I will continue to focus on executing our growth strategy and assisting in a smooth CEO transition."  

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs